← All New York bills

S03203Introduced in the Senate

Relates to preserving access to affordable drugs; provides that an agreement resolving or settling, on a final or interim basis, a patent infringement claim, in connection with the sale of a pharmaceutical product, shall be presumed to have anticompetitive effects if a nonreference drug filer receives anything of value from another company asserting patent infringement and if the nonreference drug filer agrees to limit or forego research, development, manufacturing, marketing, or sales of the nonreference drug filer's product for any period of time.

EngrossedAssembly Health

Introduced by Nathalia Fernandez, District 34

What does this bill do?

Plain-English breakdown

Writing a plain-English summary of this bill… this can take a few seconds the first time.

Official description

Relates to preserving access to affordable drugs; provides that an agreement resolving or settling, on a final or interim basis, a patent infringement claim, in connection with the sale of a pharmaceutical product, shall be presumed to have anticompetitive effects if a nonreference drug filer receives anything of value from another company asserting patent infringement and if the nonreference drug filer agrees to limit or forego research, development, manufacturing, marketing, or sales of the nonreference drug filer's product for any period of time.

Where it stands

referred to health

February 24, 2026

How did lawmakers vote?

SenateStage: Senate Floor Vote - Final Passage · February 24, 2026

39

Yes

17

No

7

Absent or Not Voting

63 senators recorded in this Senate vote. Colors show vote categories only, not whether a vote was good or bad.

What do people think?

Citizen Voice

How would you vote on this bill?

An unofficial public opinion poll. It does not affect the bill or the official vote.

One response per device. Location is self-reported and not verified. Results are informal and not a scientific survey.

See how each senator voted

Bill history

  1. REFERRED TO HEALTH

  2. REPORTED AND COMMITTED TO FINANCE

  3. 1ST REPORT CAL.755

  4. 2ND REPORT CAL.

  5. ADVANCED TO THIRD READING

  6. PASSED SENATE

  7. DELIVERED TO ASSEMBLY

  8. referred to health

  9. died in assembly

  10. returned to senate

  11. REFERRED TO HEALTH

  12. 1ST REPORT CAL.304

  13. 2ND REPORT CAL.

  14. ADVANCED TO THIRD READING

  15. PASSED SENATE

  16. DELIVERED TO ASSEMBLY

  17. referred to health

Verify the information

Our commitment to neutrality

We provide factual information only. We never tell you which politicians or bills to support, and we do not rank, score, or endorse anyone.